Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2003

01-03-2003

CASE REPORT: Spontaneous Closure of Intrahepatic Portovenous Shunt in a Noncirrhotic Patient with Recurrent Encephalopathy

Authors: Norio Horiike, Tuneyuki Ninomiya, Masanori Abe, Tomoyuki Ninomiya, Hideto Iuchi, Mami Hirata, Ichiro Konishi, Toshikazu Masumoto, Kojiro Michitaka, Morikazu Onji

Published in: Digestive Diseases and Sciences | Issue 3/2003

Login to get access
Metadata
Title
CASE REPORT: Spontaneous Closure of Intrahepatic Portovenous Shunt in a Noncirrhotic Patient with Recurrent Encephalopathy
Authors
Norio Horiike
Tuneyuki Ninomiya
Masanori Abe
Tomoyuki Ninomiya
Hideto Iuchi
Mami Hirata
Ichiro Konishi
Toshikazu Masumoto
Kojiro Michitaka
Morikazu Onji
Publication date
01-03-2003
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 3/2003
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1022596901969

Other articles of this Issue 3/2003

Digestive Diseases and Sciences 3/2003 Go to the issue

Announcement

News and Notices

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine